Intra-Cellular Therapies Statistics
Total Valuation
ITCI has a market cap or net worth of $6.97 billion. The enterprise value is $6.50 billion.
| Market Cap | 6.97B |
| Enterprise Value | 6.50B |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, before market open.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ITCI has 96.81 million shares outstanding. The number of shares has increased by 1.95% in one year.
| Shares Outstanding | 96.81M |
| Shares Change (YoY) | +1.95% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 2.36% |
| Owned by Institutions (%) | 93.16% |
| Float | 94.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.04 |
| Forward PS | 10.35 |
| PB Ratio | 11.81 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.41, with a Debt / Equity ratio of 0.03.
| Current Ratio | 5.41 |
| Quick Ratio | 4.97 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -23.00% and return on invested capital (ROIC) is -26.20%.
| Return on Equity (ROE) | -23.00% |
| Return on Assets (ROA) | -19.40% |
| Return on Capital (ROIC) | -26.20% |
| Revenue Per Employee | $761,262 |
| Profits Per Employee | -$228,974 |
| Employee Count | 610 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 0.91 |
Taxes
In the past 12 months, ITCI has paid $636,000 in taxes.
| Income Tax | 636,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.34% in the last 52 weeks. The beta is 1.02, so ITCI's price volatility has been similar to the market average.
| Beta (1Y) | 1.02 |
| 52-Week Price Change | +18.34% |
| 50-Day Moving Average | 69.43 |
| 200-Day Moving Average | 62.28 |
| Relative Strength Index (RSI) | 53.55 |
| Average Volume (30 Days) | 963,533 |
Short Selling Information
The latest short interest is 3.59 million, so 3.71% of the outstanding shares have been sold short.
| Short Interest | 3.59M |
| Short Previous Month | 3.47M |
| Short % of Shares Out | 3.71% |
| Short % of Float | 3.79% |
| Short Ratio (days to cover) | 6.03 |
Income Statement
In the last 12 months, ITCI had revenue of $464.37 million and -$139.67 million in losses. Loss per share was -$1.46.
| Revenue | 464.37M |
| Gross Profit | 430.63M |
| Operating Income | -159.38M |
| Pretax Income | -139.04M |
| Net Income | -139.67M |
| EBITDA | -138.51M |
| EBIT | -139.04M |
| Loss Per Share | -$1.46 |
Balance Sheet
The company has $499.69 million in cash and $16.94 million in debt, giving a net cash position of $482.75 million or $4.99 per share.
| Cash & Cash Equivalents | 499.69M |
| Total Debt | 16.94M |
| Net Cash | 482.75M |
| Net Cash Per Share | $4.99 |
| Equity / Book Value | 591.42M |
| Book Value Per Share | 6.11 |
| Working Capital | 544.25M |
Cash Flow
In the last 12 months, operating cash flow was -$124.20 million and capital expenditures -$269,000, giving a free cash flow of -$124.47 million.
| Operating Cash Flow | -124.20M |
| Capital Expenditures | -269,000 |
| Free Cash Flow | -124.47M |
| FCF Per Share | -$1.30 |
Margins
Gross margin is 92.73%, with operating and profit margins of -34.32% and -30.08%.
| Gross Margin | 92.73% |
| Operating Margin | -34.32% |
| Pretax Margin | -29.94% |
| Profit Margin | -30.08% |
| EBITDA Margin | -29.83% |
| EBIT Margin | -29.94% |
| FCF Margin | -26.80% |
Dividends & Yields
ITCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.95% |
| Shareholder Yield | -1.95% |
| Earnings Yield | -2.00% |
| FCF Yield | -1.78% |
Analyst Forecast
The average price target for ITCI is $90.33, which is 25.05% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $90.33 |
| Price Target Difference | 25.05% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 39.45% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ITCI has an Altman Z-Score of 28.41 and a Piotroski F-Score of 4.
| Altman Z-Score | 28.41 |
| Piotroski F-Score | 4 |